000 | 01614 a2200457 4500 | ||
---|---|---|---|
005 | 20250513183444.0 | ||
264 | 0 | _c19990617 | |
008 | 199906s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGrassilli, E | |
245 | 0 | 0 |
_aResistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction. _h[electronic resource] |
260 |
_bCancer research _cMay 1999 |
||
300 |
_a2451-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCell Cycle Proteins |
650 | 0 | 4 |
_aCeramides _xpharmacology |
650 | 0 | 4 |
_aChloramphenicol O-Acetyltransferase _xbiosynthesis |
650 | 0 | 4 |
_aDNA-Binding Proteins _xphysiology |
650 | 0 | 4 |
_aDexamethasone _xpharmacology |
650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 | _aGenes, Reporter |
650 | 0 | 4 | _aGenes, bcl-2 |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aPromoter Regions, Genetic |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xbiosynthesis |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xbiosynthesis |
650 | 0 | 4 | _aRegulatory Sequences, Nucleic Acid |
650 | 0 | 4 |
_aT-Lymphocytes _xmetabolism |
650 | 0 | 4 |
_aTrans-Activators _xphysiology |
650 | 0 | 4 | _aTranscription, Genetic |
650 | 0 | 4 | _aTransfection |
700 | 1 | _aSalomoni, P | |
700 | 1 | _aPerrotti, D | |
700 | 1 | _aFranceschi, C | |
700 | 1 | _aCalabretta, B | |
773 | 0 |
_tCancer research _gvol. 59 _gno. 10 _gp. 2451-6 |
|
999 |
_c10303440 _d10303440 |